Covered recipient · General Payments record
RAWAN J DAYAH
Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology
General Payments · PY2024
$149.97
- Reported across 8 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $149.97 | 8 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $103.75 | 5 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $31.67 | 2 |
| INTERCEPT PHARMACEUTICALS, INC. | $14.55 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $149.97 | 8 |
Payment records · PY2024 (8)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Intercept Pharmaceuticals, Inc. | $14.55 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113641287 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.96 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153563812 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.71 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153474842 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.50 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137525890 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.57 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137525894 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.21 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137525898 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $20.47 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137525902 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $21.00 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137525906 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.